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T-cell negative selection <p>A transcription profiling study, together with genetic linkage data, provides a molecular map of the T-cell negative selection response  <it>in vivo</it>.</p>
Abstract
Background: T cells in the thymus undergo opposing positive and negative selection processes so
that the only T cells entering circulation are those bearing a T cell receptor (TCR) with a low
affinity for self. The mechanism differentiating negative from positive selection is poorly
understood, despite the fact that inherited defects in negative selection underlie organ-specific
autoimmune disease in AIRE-deficient people and the non-obese diabetic (NOD) mouse strain
Results: Here we use homogeneous populations of T cells undergoing either positive or negative
selection in vivo together with genome-wide transcription profiling on microarrays to identify the
gene expression differences underlying negative selection to an Aire-dependent organ-specific
antigen, including the upregulation of a genomic cluster in the cytogenetic band 2F. Analysis of
defective negative selection in the autoimmune-prone NOD strain demonstrates a global
impairment in the induction of the negative selection response gene set, but little difference in
positive selection response genes. Combining expression differences with genetic linkage data, we
identify differentially expressed candidate genes, including Bim, Bnip3, Smox, Pdrg1, Id1, Pdcd1, Ly6c,
Pdia3, Trim30 and Trim12.
Conclusion: The data provide a molecular map of the negative selection response in vivo and, by
analysis of deviations from this pathway in the autoimmune susceptible NOD strain, suggest that
susceptibility arises from small expression differences in genes acting at multiple points in the
pathway between the TCR and cell death.
Background
Immunological self-tolerance depends upon negative selec-
tion in the thymus, whereby T cells bearing T cell receptors
(TCRs) with high avidity for self peptide-major histocompat-
ibility complex (MHC) complexes are purged from the devel-
oping repertoire before they become functionally active in the
periphery [1]. Negative selection occurs by TCR-induced
apoptosis during the transition of immature CD4+8+ double
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positive (DP) cells into mature CD4+ or CD8+ single positive
(SP) cells. Nevertheless, a measure of TCR signaling is
required for thymocytes to mature from DP into SP cells, an
opposite process requiring a weak avidity for self peptide-
MHC in order to initiate the changes of cell survival and mat-
uration referred to as positive selection. It is thought that
these two opposite processes, of cell survival or death, initi-
ated by binding of the same receptor to its ligand, are control-
led by quantitative differences in TCR affinity for self peptide-
MHC that are translated into qualitatively opposite cellular
responses. However, the molecular basis by which the two
processes are differentially controlled and how the cellular
responses initiated are achieved are unclear [2].
Recent studies have found that inherited defects in negative
selection underlie autoimmune disease. In the human disor-
der autoimmune polyendocrinopathy syndrome type 1,
defects in the AIRE gene reduce transcription of organ-spe-
cific genes in the thymus so that organ-reactive T cells are not
negatively selected [3-5]. The non-obese diabetic (NOD)
mouse strain is an intensely studied model for human
autoimmune diabetes, as well as being susceptible to other
autoimmune disorders [6], and displays a striking cellular
deficiency in MHC class II- [7,8] and class I-restricted nega-
tive selection [9], compared to non-autoimmune-prone
strains. Elucidating the molecular basis for defective negative
selection in NOD mice may shed light on the process of differ-
entiating negative from positive selection and the pathogene-
sis of human autoimmunity.
The NOD thymic deletion defect is T cell autonomous [7,8]
and represents a quantitative (approximately ten-fold)
decrease in negative selection efficiency to membrane-bound
or soluble proteins, regardless of low or high thymic expres-
sion controlled by organ-specific or systemic promoters [10].
Genetic linkage studies between the C57BL10.H2k (B10k) and
NOD strains identified four NOD-derived recessive loci that
contribute to defective negative selection in vivo, by tracing
CD4 T cell deletion triggered in the thymus of transgenic mice
by expression of an Aire-dependent antigen (insHEL) that
mirrors the expression of the insulin gene itself [10]. As would
be expected, the four defective deletion loci correspond to
four NOD loci known to contribute to diabetes susceptibility,
linked to the markers D7mit101,  D15mit229,  D2mit490/
Idd13  and  D1mit181/Idd5. Parallel analyses in vitro, in a
thymic organ culture system with exogenously added antigen,
found NOD loci that acted dominantly to interfere with apop-
tosis linked to two recessive diabetes susceptibility loci, Idd5
and Idd3 [11].
Gene expression profiling on microarrays provides an oppor-
tunity to visualize the molecular differentiation of negative
from positive selection and defects in negative selection at a
global level. Several key questions can, in principle, be
addressed. First, does negative selection involve induction or
repression of a unique set of genes, or simply quantitatively
exaggerated changes in the same set of genes as positive selec-
tion? Does the negative selection defect in NOD mice inter-
fere with all or only a small number of negative selection
genes, or does it cause a new profile of counter-regulatory
genes to be triggered, and does it equally affect positive selec-
tion gene responses? Several studies have begun to explore
this approach, although they have been limited by complica-
tions, such as premature negative selection at the double neg-
ative (DN) to DP transition, pooling of developmental
subsets, TCR heterogeneity, and the peripheral cytokine
storm that is produced after cognate antigen injection [12-15].
Here we extend a preliminary published analysis [10] using
an approach that provides a unique opportunity to visualize
the global expression changes under physiological in vivo
conditions of negative and positive selection. The model
employs TCR transgenic mice to trace selection of T cells with
a homogeneous TCR recognizing a well-characterized high
affinity peptide-MHC agonist, hen egg lysozyme (HEL) 46-
61/I-Ak. This TCR is expressed at low levels on DP cells, and
promotes positive selection into TCRhi CD4+ SP cells follow-
ing the physiological pathway and induction of markers such
as CD69 and CCR7 [10]. When the TCR transgenic is crossed
to insHEL transgenic mice on the non-autoimmune B10k
strain background, the insulin-promoter activates Aire-
dependent transcription to produce low levels of HEL antigen
in thymic medullary epithelial cells, triggering negative selec-
tion at the physiological stage during the transition from cor-
tical DP cells to medullary SP cells. Unlike thymocyte
apoptosis initiated through the intravenous injection of anti-
gen or anti-TCR antibodies, deletion of HEL-reactive thymo-
cytes by endogenous presentation of HEL activates a
physiological apoptotic process that is T cell intrinsic, with
efficient deletion of HEL-reactive thymocytes at various dilu-
tions of precursor frequency and no apoptosis of neighboring
non-HEL-specific thymocytes (data not shown). This system
of negative selection also has the advantage of faithfully rep-
licating the expression pattern of a key autoantigen in human
disease, insulin. By comparing global gene expression in
homogeneous subsets of sorted cells from these mice, either
pre-selection or undergoing positive or negative selection, we
present here a detailed analysis of the gene expression differ-
ences distinguishing negative from positive selection in a
non-autoimmune prone strain, and analyze the underlying
defect in negative selection in the autoimmune NOD strain.
Results and discussion
Global gene expression changes differentiating positive 
and negative thymocyte selection in the B10k strain
To characterize the gene expression changes occurring during
positive and negative selection in a non-autoimmune strain,
gene expression profiles were measured in three relatively
homogeneous thymocyte populations from the B10k strain
[10]. Pre-selection thymocytes ('PreS') that had not yet
received positive or negative selection signals were identifiedhttp://genomebiology.com/2007/8/1/R12 Genome Biology 2007,     Volume 8, Issue 1, Article R12       Liston et al. R12.3
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as CD4+8+ DP cells that are negative for CD69 and 1G12 TCR
clonotype and sorted from TCR transgenic and TCR insHEL
double transgenic mice. Early single positive cells that were
beginning to undergo positive selection (S+) were sorted from
TCR transgenic mice as CD4+CD8lowCD69+1G12+ cells. Early
single positive cells with an identical cell surface phenotype
but beginning to undergo negative selection (S-) were sorted
from TCR insHEL double transgenic animals. Three inde-
pendent pools of mRNA from sorted cells were analyzed by
labeling and hybridization to Affymetrix 430A microarrays
and normalized using MAS 5.0. MAS 5.0 was used as the nor-
malization method in preference to more precise project-
based model fitting systems, such as RMA, GCRMA and PLM,
due to advantages in simple reduction of the false discovery
rate. Use of the MAS 5.0 normalization method produces
'present' and 'absent' calls and, when used as a filtering
device, this has been demonstrated to reduce the false discov-
ery rate with little true cost to the true positive rate [16]. Fur-
thermore, by taking the mismatch probe into consideration,
MAS 5.0 reduces the level of false positives based on cross-
hybridization [16]. It should be noted that all normalization
methods involve a trade-off of accuracy or precision at vari-
ous levels and, while MAS 5.0 performs strongly for back-
ground correction and medium and high intensity signals
[17], it is less accurate than some alternatives for probesets in
the low intensity range [18,19]. The complete dataset, with
raw values and statistical analysis is given in Additional data
file 1 and has been deposited in the NCBI Gene Expression
Omnibus (GEO) [20] accessible through GEO Series acces-
sion number GSE3997.
We first performed a global analysis of the differences in gene
expression between negative and positive selection and pre-
selection by measuring the Euclidian distance between condi-
tions (Figure 1). Measuring Euclidian distance involves treat-
ing each condition as a single point in n-dimensional space,
where each dimension is the expression of a single probeset.
The distance between two conditions can then be calculated
as the straight line ('ordinary') distance between the two
points (conditions), so that, for example, a low value between
two conditions indicates that they have similar values for
gene expression, while a high value between two conditions
indicates that they have different values for gene expression
[21]. The advantage of Euclidian distance is that it is an
approximation of the closeness of global gene expression pro-
files under different conditions, independent of classification
of gene changes as significant or non-significant by including
the number of genes that are unchanged, and the degree of
change in differentially expressed genes (thus allowing subtle
changes in large numbers of genes, which would not neces-
sarily be detected if a statistical threshold was required, to
impact global distance). Using Euclidean distance as the
measure of global 'closeness', the largest difference was
between pre-selection thymocytes and selecting thymocytes
(both positive and negative selection). Negative selection was
closer to the pre-selection condition than positive selection.
Individual gene expression changes were then analyzed in an
independent method of assessment, by assigning probesets
into categories based on statistical significance of gene
expression pattern in the 3 replicates, allowing categorization
into 12 possible patterns. Assignment to the 12 patterns was
based only on the direction of significant gene expression
change rather than degree of change (Figure 2). Global
expression 'closeness' could then be estimated by comparing
the number of probesets that fit each category.
This measure of global expression 'closeness' between condi-
tions gave a result consistent with the Euclidean analysis,
where the pattern categories with the largest number of
probesets were those (patterns A and G in Figure 2) display-
ing an expression difference between pre-selection and selec-
tion (both positive and negative selection) but no difference
between positive and negative selection. These are likely to
represent genes that are developmentally regulated as part of
the differentiation of immature DP cells into more mature
early SP cells. Some may be induced or repressed by TCR sig-
naling mechanisms that are unable to distinguish between
TCR engagement by weak positively selecting agonists and
the strong negatively selecting agonist. Pattern A comprised
531 probesets that were induced during maturation/selec-
tion, and pattern G comprised 692 probesets that were
repressed. The induced genes included well established
markers and mediators of maturity, Tcr, Ccr7, S1P1 and IL7R,
and genes that are known to be targets of positive and
Global gene expression differences induced upon positive or negative  selection on the B10k and NODk genetic backgrounds Figure 1
Global gene expression differences induced upon positive or negative 
selection on the B10k and NODk genetic backgrounds. The global 
difference in gene expression between conditions was calculated as a 
Euclidean distance, taking into account the number of genes with 
differential expression, and the scale of differential expression, for each 
replicate chip. Euclidean distances are represented as the distance 
between conditions for both the B10k and NODk genetic backgrounds, 
with the average positions of groups located at the apexes of the triangles. 
Dotted lines correspond to the Euclidean distance between B10k and 
NODk genetic backgrounds, for the same population.
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Patterns of gene expression changes induced by positive and negative selection in the B10k and NODk strains Figure 2
Patterns of gene expression changes induced by positive and negative selection in the B10k and NODk strains. Analysis of Affymetrix GeneChip data 
segregated those probesets that were significantly changed upon positive and/or negative selection (p < 0.005) into patterns A to F based on logical sets of 
significant contrasts (p < 0.05), where patterns are defined by the relative expression during pre-selection (PreS, left), positive selection (S+, middle) and 
negative selection (S-, right). The number of probesets falling into each pattern in B10k and NODk mice is listed on the expression pattern. Assignment of 
probesets to patterns was based only on direction of change, thus the graphical depictions do not represent the degree of change.
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Genome Biology 2007, 8:R12
negative selection TCR signals, such as the calcineurin-
response genes Ian1,  Egr2  and  CD52  and ERK-response
genes Nab2 and Zfp36l1. The repressed genes included Rag1,
preTαβ, CD8α and CD8β, known to be involved in thymocyte
maturation changes, and cell cycle genes Cdc7,  Cdk2,
Cdk2ap1, and Cdk4, which are consistent with the exit from
cell cycle that accompanies maturation of early DP cells,
which are cycling, into later DP and SP cells, which are non-
cycling. The identification of these expected expression
changes acts as an internal validation of the dataset.
As well as these previously identified markers of positive and
negative selection, several important T cell regulatory genes
were also found here to be upregulated in selection: those
encoding nucleic acid binding proteins, such as Bcl3 [22],
Dicer1[23], Fosb [24], Hivep1 [14], Irf1 [25], Irf4 [14], Irf7
[26], JunB [27], Klf2 [28], Nfat5 [29], Rora [30], Stat1 [13],
and Stat6 [31]; signaling-associated genes Ccnd2 [14], Evl
[32], Hspa5 [33], Ly9 [34], Mcl1 [35], Ndfip1 [33], Psen2
[36],  Rassf5  [37],  Upf2  [38] and Zfpn1a  [39]; and those
encoding receptors, such as Crry [40], Gpr83 [41], 2-K1 [42],
Ms4a6b [43], Sema4a [43], Slamf1 [43], Tlr1 [44], Tnfsf11
[45], and Tslpr [46].
Previously unassociated genes identified as part of this anal-
ysis are, therefore, excellent candidates for novel maturation
markers, and include those encoding nucleic acid binding
proteins, such as 1810007M14Rik, AA408868, Aptx, Arts1,
D11Lgp2e,  D1Ertd161e,  Ddef1,  Ddx19b (2810457M08Rik),
Dedd2,  Dnmt3a,  Elk3,  Hnrpa1,  Hrb,  Ifih1,  Isgf3g,  Mxd4,
Nab1,  Rab8b,  Rbms2,  Rnaset2,  Rpl12,  Rpo1-1,  Skil
(9130011J04Rik), Sp100, Tcf3, Tef, Trim21, Trim30, Wasl,
Zbp1, Zcchc7, Zfp260, Zfp313, and Zfp445 (AW610627); sig-
naling-associated genes Bin1, Dlgh1, Myd88, Nedd9, Pacsin1,
Pscdbp, Sdc3, Shkbp1, Sytl2, Traf1, Vps28, Xpo6; and those
encoding receptors, such as 1810011E08Rik,  Brd8,  Cd9,
Folr4,  Ptger2, Ptgir,  Sorl1, and Tlr2. The complete set of
genes identified in this category is listed in Additional data
file 2.
The next largest pattern categories comprised probesets that
were unique to positive selection, consistent with this condi-
tion being the most differentiated based on the Euclidean
analysis. These categories (Figure 2) included genes that were
induced (patterns B and C) or repressed (patterns H and I)
during positive selection, but were either not altered at all
during negative selection (C and I) or underwent a change of
lesser magnitude but in the same direction (B and H). Genes
in these categories are candidates for translating TCR engage-
ment by weak agonists into survival and maturation rather
t h a n  n e g a t i v e  s e l e c t i o n .  H o w e v e r ,  t h i s  c a t e g o r y  w i l l  a l s o
include genes that are developmentally regulated at later
stages of SP cell maturation, after CD69 induction and
increased TCR surface expression, since negative selection
will remove SP cells before reaching this stage. Patterns B and
C comprised 278 probesets that were preferentially induced
during positive selection, including the well established func-
tional genes CD3ζ and the calcineurin-response gene Itgb7.
Patterns H and I comprised 394 probesets that were prefer-
entially repressed during positive selection, including devel-
opmental markers Cxcr4, CD8α, CD24a, CD25, and cell cycle
genes Cdc2, Cdc6, Cdc20, Cdc25b, Cdka2c and Myb.
As well as these previously identified markers of positive
selection, a number of important T cell regulatory genes were
also found here to be upregulated in positive selection: those
encoding nucleic acid binding proteins, such as Dbp
[33],Foxo1 [47] and Zfp67 [48]; the signaling-associated gene
Stam2 [49]; and those encoding receptors, such as Il6ra [50]
and Itgb2 [51].
Previously unassociated genes identified as part of this anal-
ysis are, therefore, excellent candidates for novel markers of
positive selection, and include those encoding nucleic acid
binding proteins, such as Bhc80, Ddb2, Ezh1, Gata1, Pcbp4,
Rbms1, Smarca2, and Trim26, Ddit3, Foxp1, Oas2, Tgif2,
and  Zfp467; signaling-associated genes Arrb1,  Bcap31,
Emid1, L1cam, Numb, Pea15, Rabip4, Rcbtb1, Rsn, Selpl, and
Sh3gl1; and those encoding receptors, such as AA691260,
D7Ertd458e, Frag1, Gpr97 Grina, Il6st, Paqr7, Robo3 and
Sh2d3c. The complete list (Additional data file 2) dramati-
cally expands the set of candidate mediators and markers for
understanding positive selection and SP cell maturation.
A smaller transcriptome of 246 probesets comprised genes
that were preferentially or selectively induced or repressed
during negative selection (patterns D, E, F, J, K, L in Figure
2), consistent with negative selection being closer to pre-
selection in the global analysis. Genes in these categories are
candidate mediators or markers of negative selection and thy-
mocyte apoptosis. Pattern categories E and K were selectively
induced or repressed during negative selection, showing no
change in expression between pre-selection cells and positive
selection. Pattern E comprised 87 probesets, including the
TCR-induced pro-apoptotic gene Bim  (Bcl2l11), which has
previously been shown to be induced selectively during nega-
tive selection in this system and is an essential mediator of
negative selection, and activation markers such as Ccr6.
Genes in patterns D and J were induced or repressed more
strongly in negative than positive selection. Probesets in these
categories are likely to include genes that report the quantita-
tive differences in TCR signaling thought to differentiate
strong TCR engagement by negative selecting agonists from
weak engagement by positively selecting agonists. Pattern D
comprised 48 probesets, including the gene encoding the thy-
mocyte apoptosis-inducing transcription factor, Nur77,
markers of activated T cells or regulatory T cells, Gitrd, Ox40
and 41bb, and the ERK-response gene Fos. Category F and L
comprised a small number of probesets that exhibited a
change in expression during negative selection that was in the
opposite direction to that induced during positive selection.R12.6 Genome Biology 2007,     Volume 8, Issue 1, Article R12       Liston et al. http://genomebiology.com/2007/8/1/R12
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Pattern L includes genes such as CD25, CD24a and Annexin
A4.
Overall, the negative selection transcriptome is quite small:
144 induced probesets, and 102 repressed probesets. By con-
trast, positive selection of early DP thymocytes into early SP
thymocytes induced 809 probesets and repressed 1,086
probesets - a transcriptional program that is eight-fold larger.
A complete list of the positive and negative selection tran-
scriptomes, all the genes falling into patterns A to L, in the
B10k strain is given in Additional data file 2.
Genomic localization of gene expression changes 
induced by selection on the B10k background
Recent studies have found that sets of genes induced by sim-
ilar stimuli can co-localize in genomic clusters [52]. To deter-
mine if positive or negative selection likewise work by the
activation or suppression of broad clusters of genes we que-
ried the data to identify cytogenetic bands with a significantly
increased proportion of induced or repressed genes, normal-
ized to their gene density.
Focusing first on genes associated with positive selection,
there is evidence for a small degree of gene expression change
by cytogenetic band. Six cytogenetic bands were broadly sup-
pressed upon positive selection, and no cytogenetic bands
were broadly activated. Of the six altered cytogenetic bands,
three meet stringent false discovery rates, 12F, 3B and 2F
(Table 1).
The gene expression changes induced upon negative selec-
tion, by contrast, are highly localized. While the global differ-
ence (Euclidian distance) between positive selection and
negative selection is only half that of positive selection to pre-
selection (Figure 1), a greater number of cytogenetic bands
show enrichment of gene expression differences. That is,
while fewer genes were changed, and with a lesser magnitude,
in positive selection when compared to negative selection
than in positive selection compared to pre-selection, the
genes that were differentially expressed were highly co-local-
ized to certain genomic regions. One region was broadly acti-
vated in response to negative selection, 2F, while seven
regions were broadly suppressed upon negative selection, of
which two meet stringent false discovery rates, 11E and 6B
(Table 1). Region 2F is also of interest because it is a region
that contains a cluster of genes that decreased in expression
during positive selection (Figure 3a), and a cluster of genes
that increased in expression during negative selection (Figure
3b). The induced and repressed clusters are, however, largely
distinct, with little correlation (Figure 3d). Of significance,
the key pro-apoptotic gene Bim is encoded within 2F. Bim is
controlled at least partially by chromatin structure, as histone
deacetylase inhibition allows the spontaneous induction of
Bim followed by apoptosis [53]. Of the 2F probesets changed
by negative selection in the B10k strain, the highest level of
upregulation is observed in Dut, Cops2, Dusp2, Bub1, Bim,
Mertk,  Smox,  6330527O06Rik,  LOC545465  and
2610101J03Rik. Similarly, the 2F probesets with the greatest
defects in upregulation in the NODk strain are Cops2, Galk2,
Bub1,  Bim,  1600015H20Rik,  IL1a,  Smox,  Bmp2,  Hao1,
6330527O06Rik  and  2610101J03Rik. These data generate
the hypothesis that the cytogenetic band 2F contains a con-
centration of apoptotic initiators for negative selection that
may be coregulated by chromatin structure.
Global gene expression changes induced upon positive 
and negative thymocyte selection in the NODk strain
In parallel with the above analyses of negative and positive
selection in B10k mice, the same cell subset markers, sorting
methods, and mRNA labeling and hybridization to microar-
rays were applied to pre-selection (PreS), early positive selec-
tion (S+) and early negative selection (S-) thymocytes from
TCR and TCR insHEL animals on the NOD.H2k strain back-
ground. This allowed developmentally matched, homogene-
ous populations of T cells to be traced during positive and
negative selection using the same TCR and self peptide-MHC
ligands, but carrying all the NOD genomic differences from
B10 with the exception of the congenically matched H2k hap-
lotype.
The global gene expression differences between pre-selection
DP cells and early SP cells undergoing positive or negative
selection were first used to compare these states by Euclidian
distance (Figure 1). The difference between pre-selection and
positive selection thymocytes was similar on the NODk back-
ground (23.4 units) to that observed on the B10k background
(26.7). On the NOD background, however, there was much
less difference between positive and negative selection, with
the Euclidean distance between these states decreased from
13.9 in B10k to 8.9 in NOD.
Individual gene expression differences between pre-selec-
tion, positive selection and negative selection on the NOD
background were categorized into the same 12 patterns, as
conducted above for the equivalent cells from B10 strain ani-
mals (Figure 2).
Focusing first on patterns A and G, representing probesets
that were induced or repressed equivalently during positive
or negative selection, these categories contain the largest
number of genes that were induced (787 probesets) or
repressed (994 probesets), which are comparable to the num-
bers observed for these categories in the B10 strain (Figure 2).
Again, category A includes genes that are developmentally
increased during maturation from DP to SP cells, such as
IL7R, and genes that are induced by TCR signals during pos-
itive and negative selection, such as calcineurin-response
genes Ian1, Egr2 and CD52 and ERK-response genes Nab2
and Zfp36l1. In total, 240 of the probesets assigned to cate-
gory A in NOD were also assigned to this category in B10. The
stringent cut-offs used to assign probesets to pattern catego-
ries underestimated the similarity of gene expression duringhttp://genomebiology.com/2007/8/1/R12 Genome Biology 2007,     Volume 8, Issue 1, Article R12       Liston et al. R12.7
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DP to SP maturation on the two strain backgrounds, because
only 39 of the 531 pattern A probesets in B10 thymocytes have
significantly different values from NOD for the corresponding
cell types. Likewise, genes that were decreased during matu-
ration (pattern G) included expected developmentally regu-
lated genes such as Rag1, Cd8α, PreTα and cell cycle genes.
Of the 692 B10 pattern G probesets, only 56 have significantly
different values to NOD for both positive and negative selec-
tion. Thus, the NOD background had little effect on gene
expression changes associated with early SP maturation from
pre-selection DP cells.
By contrast, the NOD background has markedly reduced
numbers of genes with expression patterns that differentiate
negative from positive selection (patterns B to F and H to L),
consistent with the smaller Euclidean distance between these
Table 1
Genomic regions with enriched gene expression changes
Cytogenetic band Size* NES† NOM p val‡ FDR q val§
Regions enriched for gene expression changes during positive selection (B10k)
Decreased in positive selection
chr12 F 69 1.8 0.002 0.05
chr3 B 29 1.5 0.035 0.24
chr2 F 100 1.5 0.009 0.24
Regions enriched for gene expression changes during negative selection (B10k)
Increased in negative selection
chr2 F 100 1.7 0.002 0.08
Decreased in negative selection
chr11 E 206 -1.7 0.000 0.06
chr6 B 138 -1.5 0.000 0.24
Regions enriched for expression differences between strains in pre-selection thymocytes
Increased in B10k
chr8 E 110 1.6 0.003 0.17
chr7 E 103 1.6 0.000 0.13
chr18 E 91 1.6 0.008 0.13
chr12 F 69 1.5 0.012 0.14
chr6 C 101 1.5 0.010 0.12
chr1 B 48 1.5 0.030 0.16
chr15 D 99 1.5 0.011 0.14
chr5 F 175 1.4 0.018 0.22
chr10 C 204 1.4 0.007 0.22
chr19 A 199 1.4 0.009 0.21
chr4 E 126 1.4 0.030 0.25
Decreased in B10k
chrX F 109 -2.4 0.000 0.00
chr3 E 43 -1.9 0.003 0.01
chrX D 25 -1.8 0.004 0.01
chr3 H 76 -1.8 0.003 0.01
chr5 C 66 -1.7 0.000 0.03
chr12 C 101 -1.5 0.008 0.09
chr1 A 39 -1.5 0.017 0.09
chrX A 207 -1.5 0.010 0.13
Regions with enriched strain expression differences during negative selection
Increased in B10k
chr2 F 100 1.8 0.002 0.05
chr3 A 61 1.6 0.008 0.19
*Size: number of genes in the cytogenetic band represented by Affymetrix probesets. †NES: normalized (multiplicative rescaling) enrichment score. 
‡NOM p val: nominal p value from the null distribution of the gene set. §FDR q val: false discovery rate q values (only false discovery rate < 0.25 have 
been included).R12.8 Genome Biology 2007,     Volume 8, Issue 1, Article R12       Liston et al. http://genomebiology.com/2007/8/1/R12
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Figure 3 (see legend on next page)
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two states in the global analysis. Thus, of the patterns with
increased expression in both positive and negative selection
(A, B, D), 79% show the same degree of regulation during pos-
itive and negative selection (assigned to pattern A) in B10k
mice, but 94% show the same degree of regulation in NODk
mice (with NODk  pattern A containing many probesets
assigned to patterns B or C in B10k mice). Likewise, of the pat-
terns with decreased expression in both positive and negative
selection (G, H, J), 72% show the same degree of regulation
(assigned to pattern G) in B10k mice, but 95% show the same
degree of regulation in NODk mice. By this assessment, posi-
tive and negative selection are less distinct in NODk mice than
in B10k mice.
Focusing specifically on genes that were preferentially or
selectively induced (patterns D, E, L) or repressed (J, K, F)
during negative selection revealed a global dampening of the
negative selection response in the NOD background (Figure
4 ) .  P a t t e r n s  D ,  E ,  a n d  L ,  c o mprising probesets that were
induced during negative selection either selectively (E, L) or
to higher levels than during positive selection (D), contained
only 66 probesets in NOD mice, whereas these sets were more
than twice as large (144 probesets) on the B10 background.
Moreover, of the 144 B, E or L probesets that were specifically
induced during negative selection in B10 mice, 137 were
diminished in expression during negative selection in NOD
mice, 112 by more than 20% and 82 by a significant amount
(Figure 4a). Thus, as noted previously, Bim induction (cate-
g o r y  E  i n  B 1 0 )  i s  u n d e t e c t a b le in NOD thymocytes, while
Nur77 induction (category B in B10) is greatly diminished.
Similarly, genes that were selectively decreased in negative
selection (patterns J, K, F) accounted for only 46 probesets in
the NOD strain compared to 102 in B10. Of the 102 probesets
decreased upon negative selection in B10 mice, 100 remained
at higher levels during negative selection in NODk mice, 84 by
more than 20% and 44 significantly so (Figure 4a). Combin-
ing both transcriptional increases and decreases, of the 246
probesets specifically changed by negative selection in the
B10k mouse, 51% were significantly less changed in the NODk
mouse. By contrast, of the 531 pattern A probesets that were
increased equivalently during positive and negative selection
in the B10k mouse, only 7% had significantly different expres-
sion during negative selection in NODk compared to B10k
mice, and the majority showed similar expression (Figure
4b).
The presence of reduced upregulation and downregulation
across the entire spectrum of negative selection-specific
genes in NODk thymocytes indicates that upstream effects are
at least partially responsible. This observation, recognizable
only at a genomic level, was not predicted in previous analy-
ses that focused solely on changes in downstream effectors,
such as Bim and Nur77 [10,11]. Such a defect may be occur-
ring at the early signaling synapse, in line with a recognized
alteration of TCR signaling components, such as enhanced
Fyn kinase activity, differential activation of the Cbl pathway,
impairment of membrane-translocation of Son of sevenless
(mSOS) Ras GDP releasing factor, and the exclusion of mSOS
and Phospholipase C (PLC)-γ1 from the TCR-Grb2-Zap70
complex, resulting in hypoactivation [54]. Altered signaling
in the basal TCR apparatus may be responsible for the
reduced surface CD3 levels present on TCR transgenic thy-
mocytes (without the presence of insHEL) in the NODk strain
compared to their B10k counterparts, with a 50% reduction at
the DP stage, and a 20% reduction at the SP stage (Figure 5).
The NOD background also caused a large decrease in
probesets assigned to categories B, C, H, and I, comprising
genes that are preferentially or selectively altered during pos-
itive selection (Figure 2). This result has two non-exclusive
explanations. First, there may be a less efficient positive selec-
tion response in NOD. Alternatively, many of the genes in this
category may normally be developmentally regulated to
appear at later stages of SP cell maturation, before CD69 is
lost but at a stage when negative selection would have
removed most such cells.
Constitutive differences in thymocyte gene expression 
caused by the NOD background
In addition to the altered negative and positive selection
response above, the NOD background also had altered pre-
selection gene expression in TCRlowCD69- DP cells, which
may set the stage for altered responses when the cells encoun-
ter negative selecting antigens. Six independent pools of pre-
selection DP cells were analyzed on both B10 and NOD back-
grounds: three from TCR animals and three from TCR
insHEL animals. There were few differences between TCR
and TCR insHEL pre-selection pools within a strain back-
ground, consistent with sorting for antigen-nasïve
thymocytes that had yet to display TCRs for HEL and induce
CD69. Comparing pre-selection cells between the strains at a
global level first (Euclidian distance, Figure 1), the difference
Gene expression changes localized to cytogenetic band 2F Figure 3 (see previous page)
Gene expression changes localized to cytogenetic band 2F. Cytogenetic band 2F was analyzed for the relative expression values of Affymetrix annotated 
genes. The log2 ratio of each gene (diamonds), plotted by genomic position, is displayed for: (a) B10k PreS compared to B10k S+; (b) B10k S- compared to 
B10k S+; and (c) B10k S- compared to NODk S-. Comparisons of gene expression changes under these conditions were made by plotting the log2 ratios for 
all genes within cytogenetic band 2F against each other (diamonds) and calculating the r2 value. The distance from the origin thus reflects the degree of 
expression change. (d) Ratio of gene expression in B10k PreS compared to B10k S+ (y-axis) versus the ratio of expression in B10k S- compared to B10k S+ 
(x-axis). (e) Ratio of gene expression in B10k S- compared to NODk S- (y-axis) versus B10k S- compared to B10k S+ (x-axis). In each case the probeset 
measuring Bim expression is indicated with a red diamond. All probesets with a relative change greater than +1 or less than -1 are shaded grey and 
annotated.R12.10 Genome Biology 2007,     Volume 8, Issue 1, Article R12       Liston et al. http://genomebiology.com/2007/8/1/R12
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between these states (14.2) was approximately half that of the
difference between pre-selection DP and early positive selec-
tion SP cells (26.7), with a total of 1,484 probesets signifi-
cantly different between NOD PreS and B10 PreS (1,484
probesets). It is unknown if this degree of pre-selection diver-
gence is specific to the NODk strain, or if it is observed across
multiple strains based on comparative divergence.
In terms of genomic location, these changes are particularly
concentrated in 20 cytogenetic regions (Table 1). Twelve
regions show increased expression in B10k  pre-selection
thymocytes, eleven of which meet stringent false discovery
rates: 8E, 7E, 18E, 12F, 6C, 1B, 15D, 5F, 10C, 19A and 4E.
Likewise eight regions show increased activity in NODk pre-
selection thymocytes, all of which meet stringent false discov-
ery rates: XF, 3E, XD, 3H, 5C, 12C, 1A and XA. With regard to
the phenomenon of defective negative selection in the NODk
strain, it may be of relevance that two of these regions co-
localize with genomic loci that contribute to defective nega-
tive selection [10], 7E and 15D.
Gene expression differences between NODk and B10k strains
induced upon negative selection were also analyzed for
cytogenetic clustering. Only four cytogenetic bands show
enrichment, after eliminating regions changed in the basal
(that is, pre-selection thymocytes) state. Two regions, 2F and
3A, were broadly suppressed in the NODk strain, and two
regions were broadly activated in the NODk strain, neither of
which meet stringent false discovery rates (Table 1). The
region 2F is of particular interest for several reasons. Firstly,
this is the only region that was broadly activated upon nega-
tive selection in the B10k strain (Figure 3b). Secondly, it is one
of only two regions that show broad strain differences in reg-
ulation upon induction of negative selection, with lower activ-
ity in the NODk  strain (Figure 3c). Thirdly, this region
overlaps one of the six identified loci with a causative effect in
defective negative selection in the NODk strain [10]. A com-
parative analysis of the gene expression changes in B10k and
B10k-NODk negative selection demonstrated that this locus
Graphical representation of expression changes between the B10k and  NODk strains Figure 4
Graphical representation of expression changes between the B10k and 
NODk strains. Probesets falling in specific B10k clusters were assessed for 
the ratio of expression during negative selection in NODk:B10k mice. A 
value of 1 represents equal expression during negative selection, <1 
represents lower expression in NODk thymocytes than B10k thymocytes 
during negative selection, and >1 represents higher expression in NODk 
thymocytes than B10k thymocytes during negative selection. (a) Probeset 
patterns from the B10k analysis increased (D, E, L) or decreased (J, K, F) 
specifically during negative selection trended towards showing that the 
same probeset in NODk thymocytes had a lower/higher expression, 
respectively. (b) The probeset pattern from the B10k analysis increased 
during maturation (A) showed roughly the same level of expression during 
negative selection in NODk thymocytes (divided into random groups for 
clarity).
E
x
p
r
e
s
s
i
o
n
 
d
u
r
i
n
g
 
n
e
g
a
t
i
v
e
 
s
e
l
e
c
t
i
o
n
(
N
O
D
k
 
v
a
l
u
e
 
c
o
m
p
a
r
e
d
 
t
o
 
B
1
0
k
 
v
a
l
u
e
)
 
0
0.5
1.0
1.5
2.0
2.5
3.0
DELJ KF
B10k pattern
E
x
p
r
e
s
s
i
o
n
 
d
u
r
i
n
g
 
n
e
g
a
t
i
v
e
 
s
e
l
e
c
t
i
o
n
(
N
O
D
k
 
0
0.5
1.0
1.5
2.0
2.5
3.0
B10k pattern A
(a) (b)
 
v
a
l
u
e
 
c
o
m
p
a
r
e
d
 
t
o
 
B
1
0
k
v
a
l
u
e
)
Regulation of surface CD3 levels on 3A9 TCR transgenic thymocytes on  the B10k and NODk genetic backgrounds Figure 5
Regulation of surface CD3 levels on 3A9 TCR transgenic thymocytes on 
the B10k and NODk genetic backgrounds. 3A9 TCR transgenic mice on the 
B10k and NODk backgrounds were assessed for CD3 surface levels by 
flow cytometry, at both the DP and SP 1G12+ developmental stages. (a) 
Representative histograms for CD3 expression on DP cells and SP 1G12+ 
cells. B10k mice are shown in grey, NODk mice in white. (b) The mean 
fluorescence intensity (normalized to B10k SP 1G12+ thymocytes) and 
standard error is shown with B10k in black and NODk in white (n = 7 for 
B10 values, 17 for NOD values). Significance of differences between B10k 
and NODk groups of the same genotype are indicated by t-test p values 
about the group. t-tests comparing SP 1G12+ thymocyte expression were 
tested using a two sided t-test of the hypothesis that NODk expression 
levels are different to '100'.
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comprises the same cluster of genes that are upregulated
upon negative selection in the B10k strain and show poor
induction of gene expression in the NODk strain (Figure 3e).
These data indicate that the NODk strain has a genetic defect
preventing the efficient induction of the negative selection 2F
cluster, including Bim, preventing initiation of apoptosis.
Gene expression variants representing causal 
candidates for defective thymic deletion in NOD
Combining the global transcription profiles for NODk and
B10k pre-, positive and negative selection with linkage data
for efficiency of negative selection in the same in vivo condi-
tions [10] provides a way to identify candidate genes respon-
sible for the NOD trait of defective negative selection. While
expression differences are promising candidates for quantita-
tive traits, we recognize that this approach is unable to detect
allelic variants arising from differential mRNA splicing, such
as the Idd5 allele of Ctla4 [55], or from amino acid substitu-
tions, such as the Idd13 polymorphism in β2 m [56].
Expression pattern was first used to identify six categories of
high priority candidate genes (Figure 6, Additional data file
2). Group 1 consists of probesets that were preferentially
increased in B10k negatively selecting thymocytes (patterns
D, E and L), but were significantly less increased in NODk
counterparts. There are 77 probesets in this group, of which
14 show poor induction and 63 show no induction. Defective
apoptotic initiators could fall in this group. Group 2 consists
of probesets that were increased in B10k thymocytes upon
selection (pattern A), but were significantly less increased in
NODk mice (p < 0.05). Only 8 probesets are in this group, of
which seven show no increase upon maturation in the NODk
strain. Defective functional prerequisites for negative selec-
tion switched on during positive selection could fall in this
category. Group 3 consists of probesets that were significantly
lower in NODk thymocytes compared to B10k thymocytes for
each biological condition. There are 151 probesets in this
group, 80 of which show no development or selection-
induced differences within the NODk or B10k groups. Defec-
tive constitutively expressed prerequisites for negative selec-
tion could fall in this group. Group 4 is the reverse of group 1.
It consists of probesets that were increased in the NODk neg-
atively selecting thymocytes, but were significantly less
increased in B10k thymocytes. This group is designed to catch
candidate genes that were more strongly induced in NODk
negatively selecting thymocytes and provided protection
from negative selection. Only two probesets fall in this cate-
gory. Group 5 is the reverse of group 2. It consists of probesets
that were increased in NODk thymocytes upon selection (pat-
tern A), but were significantly less increased in B10k thymo-
cytes. This group is designed to catch NODk over-expressed
maturation-induced protective genes. Group 6 is the reverse
of group 3, comprising probesets that were significantly
higher in NODk thymocytes compared to B10k thymocytes for
each biological condition. There are 98 probesets in this
group, 48 of which show no developmental or selection-
induced differences within NODk  or B10k  thymocytes.
Constitutively over-expressed protective factors could fall in
this group.
A matrix comprising the probesets in these six categories and
the genomic location to a 30 cM bracket surrounding peak
linkage to the four regions of NODk susceptibility to defective
negative selection markers (D7mit101,  D15mit229,
D2mit490/Idd13 and D1mit181/Idd5) [10] identified 44 can-
didate probesets. Each region has 6 to 10 candidates using
this method, except for the region centered on D2mit490,
which includes the 2F cluster and has 20 candidates. These
are discussed in more detail below, as summarized in Table 2.
Of the candidate genes linked to the D7mit101 loci (Ch7, 60
cM), four genes are of particular interest (Figure 7, Table 3).
Bnip3, 8.4 cM from D7mit101, was approximately two-fold
over-expressed in NODk  thymocytes in every condition.
Bnip3 is a BH3-only protein that dimerizes with Bcl-X(L),
making a pro-apoptotic heterodimer [57,58]. Bnip3 has been
shown to translocate to the mitochondria to induce apoptosis
during CD47-induced apoptosis [59], nitric oxide induced
apoptosis in macrophages [60], hypoxic apoptosis [61], and
activation induced death of cytotoxic T cells [62]. Overexpres-
sion of Bnip3 would, therefore, be unlikely to protect NODk
thymocytes from clonal deletion. Bnip3 overexpression may
instead be a downstream effect of the NOD defective thymic
deletion allowing thymocytes to tolerate a higher level of
expression, just as Bnip3 overexpression is associated with
more aggressive tumors and poor survival in human patients
[63].  Trim30  and  Trim12  are approximately 13 cM from
D7mit101 and were poorly expressed in NODk thymocytes.
Trim30 shows an average of a 2- to 3-fold decrease in expres-
sion in NODk thymocytes (represented by three probesets,
two of which show a strong difference and a third in the 5'
untranslated region (UTR) that shows little difference), while
Trim12 shows an approximately 300-fold expression
decrease in NODk thymocytes (Figure 7). Both are members
of the tripartite motif family, with RING, B-box type 1 and 2,
and coiled coil domains [64]. Little is known about their func-
tion, but the extent of the change and putative domain func-
tion make them strong candidate genes.
A key candidate gene for the D15mit229-linked defective
thymic deletion loci (Ch15, 22 cM; Figure 8, Table 4) is Ly6c.
Ly6c is 21.1 cM from D15mit229, and was poorly expressed in
NOD thymocytes under all conditions (2.3-fold decrease; Fig-
ure 8). This reduced expression has been previously observed
to be due to a Ly6c promoter polymorphism in NOD mice,
and is thus a known cis effect [65]. Functionally, Ly6c inhibits
the signal for secretion of interleukin (IL)2 and proliferation
in peripheral CD4+ cells [65], and cross-linking of Ly6c causes
clustering of Leukocyte function associated molecule 1 (LFA-
1, CD11a/CD18) on the surface of CD8 T cells [66].R12.12 Genome Biology 2007,     Volume 8, Issue 1, Article R12       Liston et al. http://genomebiology.com/2007/8/1/R12
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Many candidate genes were identified in the 2F cytogenetic
band around D2mit490- (Ch2, 65 cM), of which four are of
particular interest (Figure 9, Table 5). Smox oxidizes sper-
mine to spermidine [67], which has been shown to induce
DNA damage and apoptosis in gastric epithelial cells [68].
The major control for Smox during polyamine-induced apop-
tosis has been shown to occur at the mRNA level [69]; there-
fore, the small increase during B10k positive selection and
large increase in negative selection could prepare B10k thy-
mocytes for apoptosis (Figure 9). The lower levels of Smox in
NODk thymocytes, and the negligible increase during nega-
tive selection, could contribute to a poor apoptotic response.
Bim/Bcl2l11 as a candidate gene has been previously vali-
dated [10], having a key role in negative selection [70,71] and
defective upregulation in the NODk strain (in three probesets;
two probesets in the 3' UTR region of one splice variant
showed little change). Another candidate gene in this region
is Id1, 8.8 cM from D2mit490. It was increased during nega-
tive selection 2.2-fold higher in B10k thymocytes than NODk
thymocytes (Figure 9), and has been shown to inhibit the
Grouping of key gene changes between NODk and B10k thymocytes Figure 6
Grouping of key gene changes between NODk and B10k thymocytes. Analysis of Affymetrix GeneChip data segregated those probesets that were 
significantly modified in a 2 × 2 × 2 F-test (p < 0.005) into groups 1 to 6 based on logical sets of significant contrasts (p < 0.05). The diagrams show relative 
changes for the mean gene expression in the pre-selection (PreS), positive selection (S+) and negative selection (S-) conditions. The number of probesets 
falling into each group is listed on the group pattern. B10k expression changes are shown in red, NODk expression changes are shown in blue.
(b)   Upregulated by positive selection    
in the B10k mouse, lower in NODk    
8 probesets
(a) Upregulated by negative selection    
in the B10k mouse, lower in NODk   
77 probesets
(c) Lower in NODk for each condition     
151 probesets (80 no internal changes)
(f) Lower in B10k for each condition      
98 probesets (48 no internal changes)
Pre-selection
Positive selection
 
Negative selection
 
Pre-selection
Positive selection
 
Negative selection
 
(d) Upregulated by negative selection     
in   the NODk mouse, lower in B10k    
2 probesets
(e) Upregulated by positive selection      
in the NODk mouse, lower in B10k    
28 probesets
(14)
(63) (2)
(1)
(7)
(3)
(25)http://genomebiology.com/2007/8/1/R12 Genome Biology 2007,     Volume 8, Issue 1, Article R12       Liston et al. R12.13
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function of E2A and Transcription factor 12 (HEB), increas-
ing the response to TCR stimulation and the sensitivity of thy-
mocytes to apoptosis [72]. Thus, Id1  induction may be
required to amplify the clonal deletion signal for apoptosis.
Pdia3, 10.9 cM from D2mit490, was expressed at 3.4-fold
higher levels in B10k thymocytes (Figure 9). Its function as an
endoplasmic reticulum chaperone required for mitomycin C-
induced death [73] indicates potential candidacy. Also of
interest is Pdrg1, 8.8 cM from D2mit490, which has previ-
ously been shown to be upregulated in response to UV radia-
tion and inhibited by p53 [74]. It is of interest because of the
basal low level observed in NODk thymocytes.
The fourth NOD locus contributing to defective negative
selection in TCR insHEL mice, linked to D1mit181 (Ch1, 43
cM), includes the genes Ctla4 and Pdcd1 (Figure 10, Table 6).
The Ctla4 gene was not differentially expressed in our analy-
sis, but it is a functional candidate because Ctla4-deficient
thymocytes are resistant to radiation-induced apoptosis [75].
The NOD Idd5 (D1mit181-linked) haplotype produces less of
an alternatively spliced Ctla4 gene product that is a constitu-
tively active inhibitor of TCR zeta phosphorylation [55,76].
The orthologous region in humans also contains a CTLA4 var-
iant and has been associated with diabetes, thyroid
autoimmunity, Addison's disease, and disease severity in
multiple sclerosis [55]. As mentioned during the preliminary
analysis [10], Pdcd1 was induced during negative selection in
B10 but not in NOD thymocytes (Figure 10). Pdcd1 (also
called PD1) has previously identified functions in negative
regulation of T cell function [77] and Pdcd10/0 mice display
reduced positive selection [78] and autoimmune symptoms
[79,80]. Furthermore, blockade of Pdcd1 induces diabetes in
NOD mice [81].
The analysis of the negative selection transcriptome here dis-
tinguishes among several distinct, but not mutually exclusive,
mechanisms accounting for defective negative selection in
NOD thymocytes: first, several downstream effectors, such as
Bim, are defective; second, the entire negative selection
induction process is reduced; third, there is a broad defect in
the induction of TCR signaling response genes (both positive
and negative selection); and fourth, the NODk strain induces
an additional, protective transcriptome during negative
selection. By comparison of the NODk strain to the B10k strain
at a global transcription level, there is no evidence for the
ectopic of an additional, 'protective' gene set, nor for an obvi-
ous defect in the TCR signaling-dependent process of positive
selection. The second possible mechanism appears correct, as
there was a global reduction by approximately 40% in the
transcriptional process of negative selection, indicating that a
defect in upstream events impacted on multiple downstream
mediators. Not exclusive from the upstream defect, several
important apoptosis effector genes, including Bim, are almost
completely absent from the NOD negative selection response,
raising the possibility that these genes are at points where
individual quantitative differences summate, with cis-acting
promoter defects having an additive effect with the defect in
upstream inductive events. In particular, the cluster of poorly
Table 2
Summary of candidate genes by loci and expression change group
D7mit101 D15mit229 D2mit490 D1mit181
Group Ch7, 60 cM Ch15, 22 cM Ch2, 65 cM Ch1, 43 cM
1115 3
2
3649 5
4
51 1
6215
Table 3
High quality candidates for the D7mit101-linked allele
Gene Probeset Group Distance (cM) Fold change Function
Tnrcba 1439246_x_a 5 6.2 1.3 Unknown
Bnip3 1422470_at 6 8.4 2.0 Vital for CD47-induced apoptosis [59], activation induced apoptosis [62], 
hypoxic apoptosis [61]
Swap70 1423543_at 1 9.8 3.1 Part of Ig recombination complex [87], Rac-GEF required for membrane 
ruffling [88]
Rab6ip1 1424015_at 6 10.0 1.8 Interacts with Rab6 [89] (Golgi-ER transport)
1500003O22Rik 1416559_at 3 12.4 1.9 unknown
Trim30 1417961_a_at 3 13.2 3.6 RING, B-box type 1 and 2, coiled coil domains [64]
Trim12 1437432_a_at 3 13.3 297 RING, B-box type 1 and 2, coiled coil domains [64]
Frag1 1424615_at 3 14.6 2.5 Potently activates fibroblast growth factor receptor [90]
LOC675851 1416366_at 3 17.8 3.1 Unknown
Hdgfrp3 1435977_at 3 19.6 2.1 Unknown
ER, endoplasmic reticulum. GEF, guanine nucleotide exchange factor.R12.14 Genome Biology 2007,     Volume 8, Issue 1, Article R12       Liston et al. http://genomebiology.com/2007/8/1/R12
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Expression of candidate genes for the D7mit101-linked defective thymic deletion allele Figure 7
Expression of candidate genes for the D7mit101-linked defective thymic deletion allele. Individual values of biological replicates from the Affymetrix 430A 
microarray chips are indicated in the biological groups of 'pre-selection' (PreS), 'positive selection' (S+) and 'negative selection' (S-). Values are represented 
in black (B10k) and white (NODk) boxes.
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induced negative selection genes in cytogenetic band 2F
around Bim raises the possibility of a cis-acting allelic varia-
tion contributing to poor induction of this locus. Of interest,
the defect is not absolute, with partial upregulation seen for
the majority of the negative selection gene set, correlating
with previous cellular data indicating that NOD thymocytes
are capable of strong negative selection when exposed to
higher levels of stimuli [10].
The candidate genes discussed above act at multiple points in
the pathway between binding to TCR of negatively selecting
peptide-MHC and triggering of thymocyte apoptosis. These
Expression of candidate genes for D15mit229-linked defective thymic deletion Figure 8
Expression of candidate genes for D15mit229-linked defective thymic deletion. Individual values of biological replicates from the Affymetrix 430A 
microarray chips are indicated in the biological groups of 'pre-selection' (PreS), 'positive selection' (S+) and 'negative selection' (S-). Values are represented 
in black (B10k) and white (NODk) boxes.
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data frame a hypothesis that defective negative selection
involves the summation of many incremental decreases in the
efficiency of this signaling pathway, caused by multiple allelic
variants at four chromosomal loci. In NOD thymocytes there
is lower surface TCR expression, and lower efficiency of TCR
signaling due to increased iCTLA4 and decreased Pdcd1 and
Id1. This general decrease in TCR signaling may then be
compounded by poor inducibility or low expression of apop-
tosis inducers Bim, Smox, Bnip3, and Pdia3. By producing a
molecular map of negative selection responses in vivo, the
results from this study open up pathways to understand the
mechanism of negative selection and the basis for its quanti-
tative variation leading to autoimmune disease.
Materials and methods
The data discussed in this publication have been deposited in
the NCBI Gene Expression Omnibus [20], as MIAME
compliant data, and are accessible through GEO Series acces-
sion number GSE3997.
Microarray preparation
As previously described [10], cell populations were purified
from healthy 6-8-week old female mice, stained in 5 μg/ml
actinomycin D and 2 μg/ml α-amanitin (Sigma-Aldrich, St
Louis, MO) with CD4- fluorescein isothiocyanate (FITC),
CD69-phosphatidylethanolamine (PE), CD8- peridinin chlo-
rophyll protein (PerCP) and 1G12 indirectly labeled with Allo-
phycocyanin (APC), then sorted with a Becton Dickinson
(Franklin Lakes, NJ) FACVantage. Sorted populations were
'early DP' (CD4+CD8+CD69-1G12-) and 'early SP'
(CD4+CD8lowCD69+1G12+). Purified RNA underwent two
rounds of in vitro RNA amplification before fragmentation
and hybridization to Affymetrix GeneChip 430A arrays
(Santa Clara, CA, USA).
Microarray data processing
The Affymetrix 430A chips were scanned using standard
Affymetrix protocols. All arrays passed routine quality con-
trol assessment for hybridization and data quality. Expres-
sion values, referred to as probeset 'signal', were calculated
using the Affymetrix GeneChip analysis software MAS 5.0,
with a scaling chosen so that each array has a trimmed mean
of 150. Following examination, the endogenous control
probesets were removed. The MAS 5.0 signal values were
then transformed to logarithms (base 2). Signal values of 0
were assigned a value of 0.1 before taking logs. Finally, the
arrays were standardized to mean zero and variance one. Ini-
tial gene filtering kept only those probesets that were called
'present' by the Affymetrix signal detection algorithm in all
replicates for at least one biological group. All statistical anal-
yses were carried out using these transformed signal values.
Statistical analysis was carried out in three data sets, one con-
sisting only of the B10k biological groups, one consisting only
of the NODk biological groups, and one consisting of both
B10k and NODk biological groups.
Assignment of probesets into gene expression patterns
Assignment of probesets to different patterns of gene expres-
sion was separately carried out on the B10k and NODk data-
sets. The patterns are defined in terms of direction of change
between means, rather than the extent of change, with assign-
ment of a change having a statistical cut-off rather than a fold-
change cut-off. For the separate B10k and NODk datasets, two
way analyses of variance (ANOVAs) were performed on each
of the selected probesets. For each probeset, if the overall F-
test for a test of mean difference was significant (p < 0.005),
the probeset was considered significantly changed. Having
established that the means were different, t-tests for the con-
trasts in means were used to determine significantly different
means. A significance level of less than 0.05 was used for
these tests. Contrasts between 'pre-selection' thymocytes
(CD4+CD8+1G12-  CD69-) from TCR transgenic and TCR
insHEL double transgenic mice showed very few
differentially expressed probesets, as is expected for popula-
tions that have not been exposed to HEL antigen due to low
expression of TCR and anatomical segregation of antigen in
the corticomedullary junction. As a consequence, these two
groups were merged and the model re-estimated for all the
selected probesets. Since there are now three groups, there
are twelve distinct patterns of up, down and no difference.
Contrasts between the means using the re-estimated models
Table 4
High quality candidates for D15mit229-linked defective thymic deletion
Gene Probeset Group Distance (cM) Fold change Function
Oxr1 1418502_a_at 1 0.1 2.7 Protection against oxidative damage [91]
6030458C11Rik 1433860_at 6 18.1 1.5 Unknown
Ly6c 1421571_a_at 3 21.1 2.3 Inhibits signal for secretion of IL2 and proliferation [65], cross-linking 
causes clustering of LFA-1 [66]
Fbxl6 1449849_a_at 3 22.0 3.1 Unknown
Rpl8 1417762_a_at 3 22.3 1.9 Structural constituent of ribosomes
Phf5a 1424170_at 3 25.4 2.1 Nuclear protein, possibly chromatin binding [92]
LFA, Leukocyte function associated molecule.http://genomebiology.com/2007/8/1/R12 Genome Biology 2007,     Volume 8, Issue 1, Article R12       Liston et al. R12.17
c
o
m
m
e
n
t
r
e
v
i
e
w
s
r
e
p
o
r
t
s
r
e
f
e
r
e
e
d
 
r
e
s
e
a
r
c
h
d
e
p
o
s
i
t
e
d
 
r
e
s
e
a
r
c
h
i
n
t
e
r
a
c
t
i
o
n
s
i
n
f
o
r
m
a
t
i
o
n
Genome Biology 2007, 8:R12
were used to assign probesets to a gene expression pattern,
based on a logical set of significant changes between the vari-
ous conditions. A three-way ANOVA model was used to
analyze the combined B10k-NODk  dataset for differential
expression between strains. The p  values are used in this
r e s e a r c h  a s  i n d i c a t i v e  o f  ' e v i d e n c e '  a n d ,  e x c e p t  i n  r a r e
instances, will not be an exact measure of probability. Model
assumptions for the use of the different tests were examined
for a small number of significant probesets and found to hold.
Following analysis, each probeset was annotated for genomic
location and gene function using the FACTS (Functional
Association/Annotation of cDNA Clones from Text/Sequence
Sources) program [82].
Expression of candidate genes for D2mit490-linked defective thymic deletion Figure 9
Expression of candidate genes for D2mit490-linked defective thymic deletion. Individual values of biological replicates from the Affymetrix 430A 
microarray chips are indicated in the biological groups of 'pre-selection' (PreS), 'positive selection' (S+) and 'negative selection' (S-). Values are represented 
in black (B10k) and white (NODk) boxes.
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Global gene expression differences
Euclidian distance is the most common measure of metric
distance, which is an approximation of the 'distance' between
gene expression from replicates in one condition to replicates
in other conditions. Euclidean distance is calculated by treat-
ing the expression of a group of probesets as a point in n-
dimensional space, where the distance from the axis in each
dimension represents the expression (the technical mean of
transformed signal value for the replicates) of a single
probeset. This produces a single point in n dimensions (where
n is the number of probesets in the group) that represents one
set of conditions, and a single point in the same n-dimen-
sional space that represents the same group of probesets
under different conditions. The Euclidean distance between
each point (representing each condition) was calculated by
using the square root of the sums of squared differences
between the points in each dimension, using the formula:
Euclidean distance = √(x1 - y1)2 + (x2 - y2)2+ (x3 - y3)2 + ...
where x is the point representing the probeset group in condi-
tion x, with each dimension x1, x2, x3, and so on being the
expression of individual probesets within the group, and y is
the point representing the probeset group in condition y, with
each dimension y1, y2, y3, and so on being the expression of
individual probesets within the group [21].
The straight line distance between the two points thus calcu-
lated represents the difference in expression of the included
probesets between the two conditions. The probeset group
used to calculate the Euclidean distance here included all
probesets present in all replicates for at least one condition,
thus creating an approximation of the genome-wide similar-
ity between two conditions [21,83,84].
Genomic clustering analysis
Gene Set Enrichment Analysis (GSEA) was used to examine
the genome for areas of differential expression by cytogenetic
band. GSEA R script (script defaults, standard method) [85]
Table 5
High quality candidates for D2mit490-linked defective thymic deletion
Gene Probeset Group Distance (cM) Fold change Function
5730494N06Rik 1452773_at 6 4.2 1.6 Unknown
Smox 1424268_at 1, 3 4.6 2.9 Oxidizes spermine to spermidine [67], resulting in DNA 
damage and apoptosis [68]
Bcl2l11/Bim 1456006_at 1426334_a_at 1 6.7 2.3 3.0 Pro-apoptotic initiator for cytokine deprivation [70] and 
TCR-stimulation of thymocytes [71]
Id1 1425895_a_at 1 8.8 2.2 Inhibits function of E2A and HEB, increases response to 
TCR stimulation, increases sensitivity to thymocyte 
apoptosis [72]
Pdrg1 1428309_s_at 3 8.8 1.9 Upregulated by UV radiation and downregulated by p53 [74]
Sqrdl 1420641_a_at 3 10.1 3.9 Disulfide oxidoreductase activity
B2 m 1427511_at 3 10.5 2.7 Component of MHC class I
Acss2 1422479_at 3 10.4 1.7 Oxidation of acetate for acetyl-CoA production (utilized 
mainly for oxidation) [93]
Pdia3 1423423_at 3 11.0 3.4 Chaperone in the ER lumen, required for mitomycin C-
induced cell death [73]
C79248 1442744_at 6 11.0 2.6 Unknown
1442745_x_at 3.1
1446148_x_at 20.5
1446147_at 11.3
Zfp106 1425331_at 3 11.5 1.5 Interacts with FYN and Grb-2 [94]
Tmem87a 1424454_at 6 11.6 6.0 Unknown
Vps39 1451720_at 6 11.6 2.0 Promotes lysosome clustering and fusion in vivo, 
downstream of rab7 [95]
Inoc1 1418125_at 3 12.2 1.6 Unknown
Ivd 1449001_at 3 12.5 1.8 Isovaleryl coenzyme A dehydrogenase
Scg5 1423150_at 5 15.6 5.6 Neuroendocrine secretory protein [96]
Rcn1 1417090_at 1 20.9 2.1 ER Ca++ binding protein [97]
LOC626832 1436462_at 6 22.8 1.9 Unknown
Polr3k 1422753_a_at 1 26.8 1.6 RNA polymerase
ER, endoplasmic reticulum. Fyn, fyn proto-oncogene. Grb, growth factor receptor binding protein. HEB, transcription factor 12.http://genomebiology.com/2007/8/1/R12 Genome Biology 2007,     Volume 8, Issue 1, Article R12       Liston et al. R12.19
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Expression of candidates for the defective thymic deletion allele linked to D1mit181 Figure 10
Expression of candidates for the defective thymic deletion allele linked to D1mit181. Individual values of biological replicates from the Affymetrix 430A 
microarray chips are indicated in the biological groups of 'pre-selection' (PreS), 'positive selection' (S+) and 'negative selection' (S-). Values are represented 
in black (B10k) and white (NODk) boxes.
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was used with the 'gene label' permutation method. Genes
represented by multiple probesets were reduced to a single
probeset with the smallest overall p value. A lower cut-off of
20 genes per cytogenetic band was used, which resulted in a
total of 113 gene sets being tested for enrichment. A false dis-
covery rate cut-off of 0.4 was initially used, with the stricter
criterion of 0.25 for regions listed. Regions with enriched
gene expression during positive selection (B10k) refer to
cytogenetic bands with an enriched number of genes with
expression differences between B10k  pre-selection thymo-
cytes and B10k positive selection thymocytes (TCR transgenic
early SP cells). Regions with enriched gene expression during
negative selection (B10k) refer to cytogenetic bands with an
enriched number of genes with expression differences
between B10k positive selection thymocytes (TCR transgenic
early SP cells) and B10k  negative selection thymocytes
(insHEL:TCR double transgenic early SP cells). Regions with
enriched strain differences in pre-selection thymocytes refer
to cytogenetic bands with an enriched number of genes with
expression differences between B10k  pre-selection thymo-
cytes and NODk  pre-selection thymocytes. Regions with
enriched strain differences induced during negative selection
refer to cytogenetic bands with an enriched number of genes
with expression differences between B10k negative selection
thymocytes (insHEL:TCR double transgenic early SP cells)
and NODk negative selection thymocytes (insHEL:TCR dou-
ble transgenic early SP cells), with any regions showing
enrichment at the pre-selection thymocyte stage removed.
Flow cytometry
We analyzed 6-10-week old mice (or 6 week post-reconstitu-
tion chimeric mice) as described previously [5,10] using the
following antibodies: 1G12 anti-clonotype [86] (gift of E
Unanue and D Peterson, Washington University, St Louis,
MO, USA) culture supernatant followed by rat anti-mouse
IgG1 allo-phycocyanin; anti-CD8α-PerCP; anti-CD4-FITC or
PE; anti-Ly5a-FITC; anti-CD3-PE; and anti-B220-PE (all
from BD PharMingen, San Jose, CA, USA).
Additional data files
The following additional data are available with the online
version of this paper. Additional data file 1 provides a com-
plete listing of statistically significant gene expression
changes. In the 'Statistics and annotation' worksheet, basic
annotation data are given for each differentially expressed
probeset, with the Affymetrix ID number, the gene symbol,
chromosome number and starting/ending location, cytoge-
netic band, gene ontology/molecular function and the
Affymetrix target description. Means and gene expression
values are given on the transformed scale. The worksheet also
contains information on the significance level of analysis of
variance tests. The tests were conducted on the transformed
gene expression values for each probeset separately. The p
value for significant differences between conditions is listed if
the parent p value is less than 0.05. Only genes that showed a
significant difference between all the means on this scale,
using a threshold of p ≤ 0.005, are included in the worksheet.
'Within B10' tests for differences within the B10k conditions
only (using only B10k condition variance data), with subtests
'Within pre' comparing the B10k pre-selection population
sorted from insHEL transgenic and non-HEL transgenic
hosts, 'PreS vs S-' comparing B10k pre-selection populations
to B10k negative selection populations, 'PreS vs S+' compar-
ing B10k pre-selection populations to B10k positive selection
populations, and 'S+ vs S-' comparing B10k positive selection
populations to B10k negative selection populations. 'Within
NOD' tests for differences within the NODk conditions only
(using only NODk condition variance data), with subtests per-
formed as per the B10k tests. 'Overall sig' tests for differences
between any conditions, with subtests comparing B10k versus
NODk populations at the pre-selection stage ('PreS'), during
negative selection ('S-') and during positive selection ('S+').
For each probeset the average expression is given as log2
scaled and normalized and arithmetic normalized data, for
each condition. Individual data for arithmetic normalized
expression are also given for each replicate (PreS 1, 2 and 3
come from non-HEL transgenic hosts, 4, 5 and 6 come from
Table 6
High quality candidates for the defective thymic deletion allele linked to D1mit181
Gene Probeset Group Distance (cM) Fold change Function
Dnajb10 1448657_a_at 3 0.5 1.7 Homology to heat shock protein DnaJ (Hsp40)
Dnpep 1437437_x_at 1 0.5 1.6 Putative aspartyl aminopeptidase function
Farslb 1423708_a_at 3 2.5 2.0 Phenylalanine-tRNA synthetase-like, beta subunit
Acadl 1448987_at 3 4.8 1.9 Involved in the initial step of mitochondrial beta-oxidation of straight-chain fatty 
acids
Pdcd1 1449835_at 1 11.8 1.9 Negative regulator of T cell function [77], reduces positive selection [78], 
blockade induces diabetes in NOD mice [81], KO has autoimmune symptoms 
[79,80]
Rps24 1453362_x_at 3 12.0 3.5 Ribosome constituent
Hspa8 1420622_a_at 1 17.6 2.0 Aid in the targeting of the MHC class II complex to endocytic compartments 
[98], regulates cell cycle [99]
Prim2 1418035_a_at 3 25.7 3.7 DNA primase [100] involved in primer initiation, elongation, and counting [101]
KO, knockout.http://genomebiology.com/2007/8/1/R12 Genome Biology 2007,     Volume 8, Issue 1, Article R12       Liston et al. R12.21
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insHEL transgenic hosts). Individual Affymetrix 'Present/
Moderate/Absent' calls are given for each replicate. In the
'Raw data' worksheet the individual data for arithmetic nor-
malized expression are given for each probeset, regardless of
statistical analysis, along with the Affymetrix target descrip-
tion. Additional data 2 lists the assignment of probesets to
expression patterns. The 'B10' worksheet contains informa-
tion on the expression profiles (patterns) for all probesets
that showed a significant difference between the means on
the transformed scale, using a threshold of p < 0.05 for the
B10k strain. Along with the Affymetrix ID are listed the gene
symbol, the pattern to which the probeset is assigned in the
B10k strain, the pattern to which the probeset is assigned in
the NODk strain, the average arithmetic (unlogged) Affyme-
trix MAS 5.0 signal values for each condition in the B10k and
NODk strains of pre-selection ('PreS'), positive selection ('S+')
and negative selection ('S-'), and the annotated molecular
function. In the 'NOD' worksheet, all probesets that meet the
significant cut-off for assignment to an expression pattern in
the NODk strain are listed, in the same manner as the 'B10'
worksheet. In the 'B10 vs NOD' worksheet, all probesets that
meet the significant cut-off for assignment to a differential
expression group between the B10k and NODk strains are
listed. Along with Affymetrix ID and gene symbol are listed
the group number, the fold-change between the relevant B10k
and NODk conditions (dependent on differential expression
group), the p values for differential expression between B10k
and NODk strains for each condition, the average arithmetic
normalized expression for each condition in the B10k and
NODk strains, and the annotated molecular function.
Additional data file 1 Complete listing of statistically significant gene expression changes In the 'Statistics and annotation' worksheet, basic annotation data  are given for each differentially expressed probeset, with the  Affymetrix ID number, the gene symbol, chromosome number and  starting/ending location, cytogenetic band, gene ontology/molecu- lar function and the Affymetrix target description. Means and gene  expression values are given on the transformed scale. The work- sheet also contains information on the significance level of analysis  of variance tests. The tests were conducted on the transformed gene  expression values for each probeset separately. The p value for sig- nificant differences between conditions is listed if the parent p  value is less than 0.05. Only genes that showed a significant differ- ence between all the means on this scale, using a threshold of p ≤  0.005, are included in the worksheet. 'Within B10' tests for differ- ences within the B10k conditions only (using only B10k condition  variance data), with subtests 'Within pre' comparing the B10k pre- selection population sorted from insHEL transgenic and non-HEL  transgenic hosts, 'PreS vs S-' comparing B10k pre-selection popula- tions to B10k negative selection populations, 'PreS vs S+' comparing  B10k pre-selection populations to B10k positive selection popula- tions, and 'S+ vs S-' comparing B10k positive selection populations  to B10k negative selection populations. 'Within NOD' tests for dif- ferences within the NODk conditions only (using only NODk condi- tion variance data), with subtests performed as per the B10k tests.  'Overall sig' tests for differences between any conditions, with sub- tests comparing B10k versus NODk populations at the pre-selection  stage ('PreS'), during negative selection ('S-') and during positive  selection ('S+'). For each probeset the average expression is given  as log2 scaled and normalized and arithmetic normalized data, for  each condition. Individual data for arithmetic normalized expres- sion are also given for each replicate (PreS 1, 2 and 3 come from  non-HEL transgenic hosts, 4, 5 and 6 come from insHEL trans- genic hosts). Individual Affymetrix 'Present/Moderate/Absent'  calls are given for each replicate. In the 'Raw data' worksheet the  individual data for arithmetic normalized expression are given for  each probeset, regardless of statistical analysis, along with the  Affymetrix target description Click here for file Additional data file 2 Assignment of probesets to expression patterns The 'B10' worksheet contains information on the expression pro- files (patterns) for all probesets that showed a significant difference  between the means on the transformed scale, using a threshold of  p < 0.05 for the B10k strain. Along with the Affymetrix ID are listed  the gene symbol, the pattern to which the probeset is assigned in  the B10k strain, the pattern to which the probeset is assigned in the  NODk strain, the average arithmetic (unlogged) Affymetrix MAS  5.0 signal values for each condition in the B10k and NODk strains of  pre-selection ('PreS'), positive selection ('S+') and negative selec- tion ('S-'), and the annotated molecular function. In the 'NOD'  worksheet, all probesets that meet the significant cut-off for assign- ment to an expression pattern in the NODk strain are listed, in the  same manner as the 'B10' worksheet. In the 'B10 vs NOD' work- sheet, all probesets that meet the significant cut-off for assignment  to a differential expression group between the B10k and NODk  strains are listed. Along with Affymetrix ID and gene symbol are  listed the group number, the fold-change between the relevant B10k  and NODk conditions (dependent on differential expression  group), the p values for differential expression between B10k and  NODk strains for each condition, the average arithmetic normalized  expression for each condition in the B10k and NODk strains, and the  annotated molecular function Click here for file
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